Ameritas Investment Partners, Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$303,429
-4.4%
6,042
+20.3%
0.01%0.0%
Q2 2023$317,390
+47.5%
5,022
+5.0%
0.01%
+33.3%
Q1 2023$215,142
-3.3%
4,7820.0%0.01%0.0%
Q4 2022$222,411
-26.1%
4,782
+4.5%
0.01%
-30.8%
Q3 2022$301,000
+30.3%
4,5760.0%0.01%
+30.0%
Q2 2022$231,000
-20.9%
4,5760.0%0.01%0.0%
Q1 2022$292,000
-40.4%
4,5760.0%0.01%
-41.2%
Q4 2021$490,000
+4.3%
4,5760.0%0.02%0.0%
Q3 2021$470,000
+15.5%
4,576
-1.1%
0.02%
+13.3%
Q2 2021$407,000
-7.1%
4,626
+2.8%
0.02%
-11.8%
Q1 2021$438,000
-15.8%
4,501
-2.9%
0.02%
-29.2%
Q4 2020$520,000
+17.1%
4,636
-3.3%
0.02%
+20.0%
Q3 2020$444,000
+18.7%
4,7930.0%0.02%
+11.1%
Q2 2020$374,000
+33.6%
4,793
+0.2%
0.02%
+12.5%
Q1 2020$280,000
-18.1%
4,785
+12.1%
0.02%
+6.7%
Q4 2019$342,000
+12.1%
4,267
+2.6%
0.02%
+7.1%
Q3 2019$305,000
-22.2%
4,1580.0%0.01%
-22.2%
Q2 2019$392,000
+42.0%
4,158
+20.8%
0.02%
+38.5%
Q1 2019$276,000
+48.4%
3,4420.0%0.01%
+30.0%
Q4 2018$186,000
-30.9%
3,4420.0%0.01%
-16.7%
Q3 2018$269,000
+23.4%
3,4420.0%0.01%
+20.0%
Q2 2018$218,000
-33.7%
3,442
-4.2%
0.01%
-37.5%
Q1 2018$329,000
+18.3%
3,592
-2.7%
0.02%
+23.1%
Q4 2017$278,000
+51.1%
3,691
+8.2%
0.01%
+44.4%
Q3 2017$184,000
+6.4%
3,4100.0%0.01%
+12.5%
Q2 2017$173,000
+113.6%
3,410
+68.9%
0.01%
+100.0%
Q1 2017$81,0002,0190.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders